David Joseph Smith, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Doctors Ln Ste 200, Clarion, PA 16214 Phone: 814-226-1950 Fax: 814-226-1956 |
Mr. Michael Stephen Pollock, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Doctors Ln, Suite 104, Clarion, PA 16214 Phone: 814-226-1950 Fax: 814-226-1951 |
Robert A Armstrong, D.O. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 18 Sportsman Dr, Suite 20, Clarion, PA 16214 Phone: 814-226-1070 Fax: 814-226-1072 |
Chong Min Park, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 24 Doctors Ln, Suite 304, Clarion, PA 16214 Phone: 814-226-7800 Fax: 814-226-7801 |
News Archive
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
Deloitte released a new report, "Innovative Strategies for Oncology Drug Development," highlighting specific drug development approaches that have enabled biotech companies to produce a substantial number of first-in-class compounds and more than $1 billion in oncology drugs while transforming the medical outlook for many cancer patients.
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
Thomson Reuters today announced that BMJ Group has selected ScholarOne Manuscripts as the peer review workflow management system for all of its journals. BMJ Group publishes 33 leading specialist titles, and the British Medical Journal, one of the world's most influential and widely read journals.
As a senior White House official heads to Capitol Hill to brief House Democrats on the health law's implementation - especially the troubled rollout of healthcare.gov, Republicans want the same opportunity.
› Verified 8 days ago